News & Events

BEAM Alliance
Members
Events

Latest news from BEAM Alliance

21 May 2025 - BEAM ALLIANCE

Two new reflection papers to help shape relevant AMR Pull incentives

Today, we publish 2 reflection papers on one of the most challenging areas still within the revision of the General…

8 April 2025 - BEAM ALLIANCE

Untreatable infections: Meeting the threat to safeguard the future of healthcare in Europe

Summary paper of AMR-event hosted by MEP Stine Bosse and MEP Eszter Lakos in Brussels April 2025

3 April 2025 - BEAM ALLIANCE

A call to revise the In Vitro Diagnostic Regulation

A centralised expertise group is needed, such as FDA’s microbiology department, to define the level of standardisation necessary and sufficient…

31 March 2025 - BEAM ALLIANCE

How armed-conflicts are fuelling AMR

AMR is already a threat to public health, a threat that grows every year and compromises many modern medical interventions.…

17 March 2025 - BEAM ALLIANCE

Publication of the 3rd edition of the beAMRometer

Beyond the figures, there is a palpable sense of frustration. The frustration of having good technology and not being able…

6 February 2025 - BEAM ALLIANCE

Join us at the AMR conference!

The AMR Conference is 2 days of updates on the latest developments in the fight against microbial resistance, from a…

No results

1 / 8

Latest news of BEAM Members

8 July 2025 - Basilea Pharmaceutica International

Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062

This additional funding is based on the successful completion of a milestone within the “Other Transaction Agreement” (OTA, agreement number 75A50124C00033) that was awarded on September 30, 2024, and which…

2 July 2025 - BioVersys

BioVersys and Shionogi Enter Into Global Research Collaboration For Broad-Spectrum Non-Tuberculous Mycobacteria (NTM) Clinical Candidate

The BV500 NTM program is derived from the company’s proprietary Ansamycin Chemistry platform. BioVersys’ research teams in Lille (France) and…

10 June 2025 - Centauri Therapeutics

Centauri Therapeutics publishes proof-of-concept data demonstrating activity of a novel bifunctional immunotherapy against Gram-negative bacterial infections

Centauri’s Alphamer platform has been uniquely developed as a powerful immune therapy that harnesses and empowers the body’s own naturally…

5 June 2025 - Basilea Pharmaceutica International

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea

Continued growth of Cresemba, particularly in China, where uptake has been especially robust, reinforces its significant clinical value for patients facing…

20 May 2025 - Basilea Pharmaceutica International

Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States

David Veitch, Chief Executive Officer of Basilea, stated: “We congratulate our partner Innoviva Specialty Therapeutics on making Zevtera commercially available…

28 April 2025 - BioVersys

BioVersys to Host Virtual KOL Event to Discuss BV100 Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter on May 7, 2025

he event will review results from the Phase 2 study evaluating BV100 for the treatment of serious infections due to…

No results

1 / 66

Events

3 March 2026

10th AMR Conference

Save the date! The 10th AMR Conference will be organized as a face-to-face event on 3-4 March 2026, in Basel.…

3 November 2025

BIO-Europe® 2025 – 31st Annual International Partnering Conference

BIO-Europe is the largest, longest-running biopharma partnering conference in Europe. It has evolved with the biotech industry to deliver an…

1 October 2025

Global AMR Innovators Conference (GAMRIC)

Save the date! The Global AMR Innovators Conference (GAMRIC), formerly the ESCMID-ASM Joint Conference on Drug Development for AMR, is…

22 July 2025

Repurposing drugs to address the crisis of antimicrobial resistance

Freda Jen, Anthony Coates and François Franceschi will discuss the potential, challenges and recent advances in repurposing medicines originally developed…

22 May 2025

REVIVE Webinar: Post-licensing clinical trials for advancing the use of antimicrobials

This webinar will showcase the importance of clinical trials after licensing antibiotics by demonstrating two major trials taking place.

3 April 2025

REVIVE Webinar: Charting new frontiers in artificial intelligence for antibiotic design

This live webinar including an interactive Q&A session will be broadcast on 3 April 2025 at 17:00-18:30 CEST.

No results

1 / 28

Legal notice | Photo credits

Connect with us

contact@beam-alliance.eu
29 Avenue Tony Garnier 69007 Lyon - France